Clearance of senescent cells during cardiac ischemia–reperfusion injury improves recovery - Archive ouverte HAL Access content directly
Journal Articles Aging Cell Year : 2020

Clearance of senescent cells during cardiac ischemia–reperfusion injury improves recovery

(1) , (1) , (1) , (1) , (1) , (1) , (1) , (2) , (1) , (3) , (1) , (4) , (4) , (1) , (3) , (1) , (1) , (1) , (5) , (1)
1
2
3
4
5
Emily Dookun
Rachael Redgrave
Pawel Palmowski
Simon Tual-Chalot
Averina Suwana
Eduard Jirkovsky
Eleanor Gill
David Grieve
Ioakim Spyridopoulos
Helen Arthur
João Passos
Gavin Richardson

Abstract

A key component of cardiac ischemia-reperfusion injury (IRI) is the increased generation of reactive oxygen species, leading to enhanced inflammation and tissue dysfunction in patients following intervention for myocardial infarction. In this study, we hypothesized that oxidative stress, due to ischemia-reperfusion, induces senescence which contributes to the pathophysiology of cardiac IRI. We demonstrate that IRI induces cellular senescence in both cardiomyocytes and interstitial cell populations and treatment with the senolytic drug navitoclax after ischemia-reperfusion improves left ventricular function, increases myocardial vascularization, and decreases scar size. SWATH-MS-based proteomics revealed that biological processes associated with fibrosis and inflammation that were increased following ischemia-reperfusion were attenuated upon senescent cell clearance. Furthermore, navitoclax treatment reduced the expression of pro-inflammatory, profibrotic, and anti-angiogenic cytokines, including interferon gamma-induced protein-10, TGF-β3, interleukin-11, interleukin-16, and fractalkine. Our study provides proof-of-concept evidence that cellular senescence contributes to impaired heart function and adverse remodeling following cardiac ischemia-reperfusion. We also establish that post-IRI the SASP plays a considerable role in the inflammatory response. Subsequently, senolytic treatment, at a clinically feasible time-point, attenuates multiple components of this response and improves clinically important parameters. Thus, cellular senescence represents a potential novel therapeutic avenue to improve patient outcomes following cardiac ischemia-reperfusion.
Fichier principal
Vignette du fichier
Aging Cell - 2020 - Dookun.pdf (2.23 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

inserm-03822453 , version 1 (20-10-2022)

Identifiers

Cite

Emily Dookun, Anna Walaszczyk, Rachael Redgrave, Pawel Palmowski, Simon Tual-Chalot, et al.. Clearance of senescent cells during cardiac ischemia–reperfusion injury improves recovery. Aging Cell, 2020, 19 (10), pp.e13249. ⟨10.1111/acel.13249⟩. ⟨inserm-03822453⟩
5 View
1 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More